Puma (PBYI) Q4 Loss Wider Than Expected, Nerlynx Sales Fall
Puma Biotechnology
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma (PBYI) Misses on Q3 Earnings, Cuts Sales View, Stock Down
SBUX,TMK,CFR,LGF,CSGP,CR,ULTI,PB,LVNTA,GWRE,THS,MOG.A,BYI,KS,MKTX,FFIN,LFUS,SWM,MANH,LOPE,FANG, PBYI,BOBE,DWRE,NWBI,HGR,FIBK,QDEL,PFPT,MHLD,EXPO,MEAS,NGVC,FWM,CRVL,BLUE,DFRG,DATA,SYRG,ASI,BRSS,REX,SILC,TESS,SNAK,AMBI,HDS Stock Quote
Puma Biotechnology
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Puma (PBYI) Q2 Loss Narrower Than Expected, Nerlynx View Cut
CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration | Business Wire
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Puma (PBYI) Beats on Q1 Earnings, Ups Nerlynx Sales View
Puma (PBYI) Q2 Loss Narrower Than Expected, Nerlynx View Cut
Challenges For The Banking Industry In 2021 - Invesbrain
Puma Biotechnology
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma (PBYI) Beats on Q1 Earnings, Ups Nerlynx Sales View
Puma Biotech's new cancer drug Nerlynx suffered a terrible quarter. What gives? | FiercePharma
